Login
$HAE
$119.97 +$0.78 (0.65%) Close

Ownership

13F as of Q2 2026 · 45.5M shares outstanding

Who owns HAE?

By type of holder
Institutions 100.0% Insiders 0.0% Everyone else 0.0%
Concentration Top 10 holders own 55.2%
BlackRock, Inc. 13.0% · Neuberger Berman Group LLC 9.2%
Institutional ownership
100.0%
0 pts vs last qtr
Institutional holders
329
+5 vs last qtr
Net shares bought
+2.0M
by institutions in Q2 2026
New / sold out
55 / 50
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Ariel Investments, LLC NEW +2.1M
  • Citadel Advisors LLC +1.3M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Aqr Capital Management LLC −1.1M
  • FMR LLC −987.8K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Haemonetics Corp in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2017–FY2026
−8.1%
−0.93% a year
Each share's claim on the business
+8.8%
grew without buying or selling a share
Spent on buybacks vs paid in stock
$910M vs $227M
over 10 fiscal years
Diluted shares, split-adjusted
45.9M50.0M54.0M2017: 51.5M shares'172018: 53.5M shares'182019: 52.9M shares'192020: 51.8M shares'202021: 51.3M shares'212022: 51.4M shares'222023: 51.4M shares'232024: 51.4M shares'242025: 50.7M shares'252026: 47.4M shares'26
Buybacks Stock-based comp
$0$112.5M$225.0M2017 buybacks: $02017 stock comp: $9.2M'172018 buybacks: $100.0M2018 stock comp: $13.0M'182019 buybacks: $160.0M2019 stock comp: $17.2M'192020 buybacks: $175.0M2020 stock comp: $20.5M'202021 buybacks: $02021 stock comp: $25.5M'212022 buybacks: $02022 stock comp: $24.4M'222023 buybacks: $75.0M2023 stock comp: $25.6M'232024 buybacks: $02024 stock comp: $28.3M'242025 buybacks: $225.0M2025 stock comp: $29.6M'252026 buybacks: $175.0M2026 stock comp: $33.8M'26

How patient are the owners?

Institutional shares by how long they've been held
5+ years70% 3–5 years2% 1–3 years13% Under 1 year15%
Quarterly turnover
18.9%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting HAE on Form 13F
B
BlackRock, Inc.
Shares
5.9M
% of company
12.99%
Change vs last qtr
+289.3K (+5.1%)
Held since
≤2021
NB
Neuberger Berman Group LLC
Shares
4.2M
% of company
9.19%
Change vs last qtr
+618.5K (+17.4%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding Haemonetics Corp, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting HAE on Form N-PORT; together they hold 50.6% of the company
IC
Position value
$119M
% of company
3.49%
% of the fund
0.10%
As of
June 30, 2026
VT
Position value
$108M
% of company
3.17%
% of the fund
0.00%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Haemonetics Corp and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
SC
Simon, Christopher
Insider
Shares
444.7K
% of company
0.98%
Change vs last qtr
—
Held since
—
BM
Basil Michelle L
Insider
Shares
68.8K
% of company
0.15%
Change vs last qtr
—
Held since
—

14 more holders behind a free account

See every insider and 5%+ holder of Haemonetics Corp.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support